These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7877686)

  • 1. Antibody catalysis of a reaction otherwise strongly disfavoured in water.
    Shabat D; Itzhaky H; Reymond JL; Keinan E
    Nature; 1995 Mar; 374(6518):143-6. PubMed ID: 7877686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A catalytic antibody against a tocopherol cyclase inhibitor.
    Manetsch R; Zheng L; Reymond MT; Woggon WD; Reymond JL
    Chemistry; 2004 May; 10(10):2487-506. PubMed ID: 15146522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition-state stabilization as a measure of the efficiency of antibody catalysis.
    Stewart JD; Benkovic SJ
    Nature; 1995 Jun; 375(6530):388-91. PubMed ID: 7760931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic cyclopropanation by antibody catalysis.
    Li T; Janda KD; Lerner RA
    Nature; 1996 Jan; 379(6563):326-7. PubMed ID: 8552185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for a disfavored elimination reaction in catalytic antibody 1D4.
    Larsen NA; Heine A; Crane L; Cravatt BF; Lerner RA; Wilson IA
    J Mol Biol; 2001 Nov; 314(1):93-102. PubMed ID: 11724535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay between binding energy and catalysis in the evolution of a catalytic antibody.
    Ulrich HD; Mundorff E; Santarsiero BD; Driggers EM; Stevens RC; Schultz PG
    Nature; 1997 Sep; 389(6648):271-5. PubMed ID: 9305839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipase-catalysed enantioselective ammonolysis of phenylglycine methyl ester in organic solvent.
    Du W; Zong M; Guo Y; Liu D
    Biotechnol Appl Biochem; 2003 Oct; 38(Pt 2):107-10. PubMed ID: 12749767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Just a near attack conformer for catalysis (chorismate to prephenate rearrangements in water, antibody, enzymes, and their mutants).
    Hur S; Bruice TC
    J Am Chem Soc; 2003 Sep; 125(35):10540-2. PubMed ID: 12940735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes.
    Wagner J; Lerner RA; Barbas CF
    Science; 1995 Dec; 270(5243):1797-800. PubMed ID: 8525368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of water in the multifaceted catalytic antibody 4B2 for allylic isomerization and Kemp elimination reactions.
    Acevedo O
    J Phys Chem B; 2009 Nov; 113(46):15372-81. PubMed ID: 19860435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate-assisted antibody catalysis.
    Deng S; Bharat N; de Prada P; Landry DW
    Org Biomol Chem; 2004 Feb; 2(3):288-90. PubMed ID: 14747854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large rate accelerations in antibody catalysis by strategic use of haptenic charge.
    Thorn SN; Daniels RG; Auditor MT; Hilvert D
    Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hapten design for the generation of catalytic antibodies.
    Thomas NR
    Appl Biochem Biotechnol; 1994; 47(2-3):345-72. PubMed ID: 7944348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
    Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
    J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Products and kinetics of the liquid-phase reaction of glyoxal catalyzed by ammonium ions (NH4(+)).
    Nozière B; Dziedzic P; Córdova A
    J Phys Chem A; 2009 Jan; 113(1):231-7. PubMed ID: 19118483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated antibody in organic media.
    Liu M; Xu M; Loh XJ; Abe H; Tsumuraya T; Fujii I; Li J; Son TI; Ito Y
    J Biosci Bioeng; 2011 May; 111(5):564-8. PubMed ID: 21277826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonspecific medium effects versus specific group positioning in the antibody and albumin catalysis of the base-promoted ring-opening reactions of benzisoxazoles.
    Hu Y; Houk KN; Kikuchi K; Hotta K; Hilvert D
    J Am Chem Soc; 2004 Jul; 126(26):8197-205. PubMed ID: 15225061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tech.Sight. Antibody design by man and nature.
    Wentworth P
    Science; 2002 Jun; 296(5576):2247-9. PubMed ID: 12077422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.